---
layout: default
title: 2 3 7 8-Tetrachlorodibenzo-P-Dioxin Aluminum Oxide
parent: 僅模型預測 (L5)
nav_order: 22
evidence_level: L5
indication_count: 0
---

# 2 3 7 8-Tetrachlorodibenzo-P-Dioxin Aluminum Oxide
{: .fs-9 }

證據等級: **L5** | 預測適應症: **0** 個
{: .fs-6 .fw-300 }

---

## 目錄
{: .no_toc .text-delta }

1. TOC
{:toc}

---

<div id="pharmacist">

## 藥師評估報告

</div>

# Multi-Substance Entry (20 Components): Insufficient Data for Drug Repurposing Evaluation

## One-Sentence Summary

This Evidence Pack contains 20 unrelated chemical substances consolidated into a single query entry (including 2,3,7,8-TCDD, benzene, glyphosate, formaldehyde, and others), rather than a single drug candidate.
The TxGNN model returned **no predicted indications**, and there are **no clinical trials or publications** associated with this combined entry.
This record cannot proceed to standard repurposing evaluation in its current form.

---

## Quick Overview

| Item | Content |
|------|---------|
| Original Indication | None on record |
| Predicted New Indication | None — TxGNN returned no predictions |
| TxGNN Prediction Score | N/A |
| Evidence Level | L5 (model prediction only — and no prediction was generated) |
| US Market Status | Not marketed |
| Number of NDAs | 0 |
| Recommended Decision | **Hold** |

---

## Why This Prediction Cannot Be Evaluated

The `inn` field in this Evidence Pack is not a single drug. It is a semicolon-delimited list of **20 chemically unrelated substances**:

| # | Substance | Category |
|---|-----------|----------|
| 1 | 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) | Persistent organic pollutant / known carcinogen |
| 2 | Aluminum oxide | Industrial abrasive / excipient |
| 3 | Antipyrine | Analgesic / diagnostic agent |
| 4 | Benzene | Industrial solvent / known carcinogen (IARC Group 1) |
| 5 | Bisphenol A | Endocrine disruptor / plasticizer |
| 6 | Carbon disulfide | Industrial chemical / neurotoxin |
| 7 | Carboxymethylcellulose sodium | Pharmaceutical excipient |
| 8 | Diethylstilbestrol | Synthetic estrogen (withdrawn from most markets) |
| 9 | Estrone | Endogenous estrogen |
| 10 | Formaldehyde solution | Fixative / known carcinogen (IARC Group 1) |
| 11 | Garlic | Food substance / herbal supplement |
| 12 | Glyphosate | Herbicide |
| 13 | Kerosene | Petroleum distillate |
| 14 | Methylparaben | Preservative / excipient |
| 15 | Naphthalene | Industrial chemical / possible carcinogen |
| 16 | Paraffin | Wax / excipient |
| 17 | Phenacetin | Withdrawn analgesic (nephrotoxic) |
| 18 | Phenol | Antiseptic / industrial chemical |
| 19 | Polytetrafluoroethylene (PTFE) | Polymer / coating material |
| 20 | Ptelea trifoliata bark | Herbal botanical |

These substances share no common therapeutic indication, mechanism of action, or pharmacological class. They cannot be evaluated as a unified drug candidate. The TxGNN model's failure to return any predictions is consistent with this data quality issue — the model could not identify a valid drug node in the knowledge graph for this concatenated query.

---

## Conclusion and Next Steps

**Decision: Hold**

**Rationale:**
This entry is the result of a data pipeline error in which 20 unrelated substances were concatenated into the `inn` field of a single candidate record. There is no drug identity, no original indication, no predicted indication, and no safety profile to evaluate.

**To proceed, the following is needed:**

- **Root cause investigation**: Identify which upstream pipeline step produced this multi-substance concatenation (check `candidate_id: TW-UNKNOWN-multi` and the `v4` generation process)
- **Re-submission as individual entries**: Each substance that is a legitimate drug candidate (e.g., Antipyrine, Diethylstilbestrol, Estrone) should be submitted as a separate Evidence Pack with its own `candidate_id`
- **Exclusion of non-drug substances**: TCDD, benzene, glyphosate, kerosene, formaldehyde, and naphthalene are environmental toxins or industrial chemicals — these should be filtered out at the data ingestion stage before reaching the repurposing pipeline
- **DrugBank ID validation gate**: The pipeline should reject any entry with `drugbank_id: null` until a valid DrugBank ID is confirmed
- **MOA and regulatory data**: For any legitimate candidates separated from this entry, DrugBank MOA and TFDA package insert data must be retrieved before safety evaluation can begin
## Disclaimer

This content is for research purposes only and does not constitute medical advice.
Clinical validation is required before any clinical application.

---

